Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Hepatitis C, Chronic 2Virus Diseases 1Liver Diseases 1Hepatitis C 1Carcinoma, Hepatocellular 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2ledipasvir, sofosbuvir drug combination 1hepatitis C immune globulin, human 1halofantrine 1VP-102 1Therapies, Investigational 1Rituximab 1Papillomavirus Vaccines 1Kidney Transplantation 1Ipilimumab 1Influenza Vaccines 1Immunoglobulin G 1Imiquimod 1Gels 1Drug Therapy 1Cantharidin 1Bevacizumab 1Antibodies, Monoclonal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Virus Diseases × ledipasvir, sofosbuvir drug combination × Clear all
NCT02868242 2020-03-02

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy

Gilead Sciences

Phase 2 Completed
19 enrolled 14 charts

Hepatitis C, Liver Diseases, Virus Diseases, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡